atop dermal ad refractory recur inflammatory skin disease various factor include here environment agent innate acquire immune barrier function particle pathogenesis helper th domain immunology milieu suggest act phase antigen b agb da secretary protein well conserve mycobacterium spec strong type cytokine induce active expect atelier conduit allergy perform vivo effect le ideas vaccine method require recent establish novel function virus vector recombin human parainfluenza type rapid highly express replicationdefici lowpathogen studi investing efficacy engine express rhpivagb mouse model induce repeat oxazolon ox challenge ear swell dermal cell infiltr serum ige level significantly suppress treat group accompany elev inγ il mra express tnα map mouse show clinic symptom group system adverse reaction respiratory tract epithelium capture effect without remark cytotox effect result might potent therapeutic tool control discord 